Crystallisation & Polymorphism for Discovery Chemists

With the increased demand for APIs (active pharmaceutical ingredients) to reach the marketplace, chemists in early stage development are expected to have a greater understanding of solid form and crystallisation. This single day event, presented by a selection of industrialists and academics in their field of expertise, will provide an introduction to this area, specifically initial crystallisation experiments, solid form selection and formulation and how these matters are handled using real industrial examples.

Lectures

• Crystallisation: why, what, how and when? Dr Simon Black, AstraZeneca
• Title to be advised, Prof Alistair Florence, University of Strathclyde
• Understanding the crystal morphology of molecular crystals from a solid-state and interfacial chemistry perspective, Prof Kevin Roberts, University of Leeds
• Cocrystals; synthesis, properties and medicinal chemistry, Prof Kim James, Peakdale
• Caffeine and Paracetamol: small molecules for big headaches, Dr Kreso Bucar, UCL
• Polymorphism studies of a preclinical candidate in a CRO environment. Lessons learnt (again), Dr David Pearson, Charles River Laboratories